Noom Med vs. NovoCare Pharmacy (Wegovy): prices, fine print, and the honest verdict

Tirzepatide pricing

Noom Med does not offer tirzepatide. NovoCare Pharmacy (Wegovy) routes patients to brand-name medication (Wegovy injectable (all doses $349), Wegovy HD 7.2 mg ($399), Wegovy oral tablets ($149 intro)): your medication cost is the manufacturer's self-pay rate (Zepbound $299–$449, Wegovy $349) or an insurance copay, plus any program fee.

Semaglutide pricing

On semaglutide, Noom Med wins at $199 versus $349 all-in — $150/mo apart. Noom Med: Semaglutide runs $199 a month all-in — capped at 0.6 mg, a quarter of the trial dose. NovoCare Pharmacy (Wegovy): Semaglutide runs $349 a month all-in at the standing rate ($199 on intro/plan terms).

Different products, not just different prices

NovoCare Pharmacy (Wegovy) fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while Noom Med sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

Noom Med: Source-verified (verified 2026-08-08); names its pharmacy — Tailor Made Compounding (named). NovoCare Pharmacy (Wegovy): Source-verified (verified 2026-08-09); names its pharmacy — Novo Nordisk direct / retail partners. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Noom Med: 12-week cycles; 12-week billing cycles. NovoCare Pharmacy (Wegovy): none; no subscription.

The semaglutide board

On semaglutide, Noom Med prices at $199 against $349 all-in. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. Noom Med publishes no figure to normalize; NovoCare Pharmacy (Wegovy) bills at manufacturer/insurance rates plus any stated program fee. 4 · Evidence tiered. Noom Med: source-verified, read 2026-08-08; NovoCare Pharmacy (Wegovy): source-verified, read 2026-08-09. 5 · Pharmacy weighed. Noom Med names Tailor Made Compounding (named); NovoCare Pharmacy (Wegovy) names Novo Nordisk direct / retail partners — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Noom Med: no membership — the medication figure is the billed figure; 12-week billing cycles; commitment: 12-week cycles. NovoCare Pharmacy (Wegovy): no membership — the medication figure is the billed figure; no subscription; commitment: none. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Noom Med carries source-verified pricing (last read 2026-08-08); pharmacy disclosure is its strong suit — Tailor Made Compounding (named), named 503A/503B partner. NovoCare Pharmacy (Wegovy) carries source-verified pricing (last read 2026-08-09); pharmacy disclosure is its strong suit — Novo Nordisk direct / retail partners, manufacturer direct. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from Noom Med to NovoCare Pharmacy (Wegovy) (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: Noom Med: shipping included; consultation included; async visit model. NovoCare Pharmacy (Wegovy): shipping included (or retail via savings card); consultation bring your own prescription; prescription required visit model; savings-card pickup at 70,000+ retail pharmacies as the mail-order alternative. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Noom Med if the semaglutide line is cheaper here. Pick NovoCare Pharmacy (Wegovy) if only the FDA-approved product will do. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

This one is a product decision more than a price decision — cheapest-possible compounded versus FDA-approved brand. Both records, with dates and sources, live in the pricing database.